Metabolic syndrome in primary aldosteronism and essential hypertension: Relationship to adiponectin gene variants

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 2, 2010, Pages 93-100

  Ronconi, V ^a   Turchi, F ^a   Rilli, S ^a   Di Mattia, D ^a   Agostinelli, L ^a   Boscaro, M ^a   Giacchetti, G ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

Adiponectin gene; Essential hypertension; Metabolic syndrome; Polymorphisms; Primary aldosteronism

Indexed keywords

ADIPONECTIN; ADIPONECTIN, HUMAN; ALDOSTERONE; BIOLOGICAL MARKER; INSULIN;

ARTICLE; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; INSULIN RESISTANCE; ITALY; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE;

ADIPONECTIN; ALDOSTERONE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; INSULIN; INSULIN RESISTANCE; ITALY; METABOLIC SYNDROME X; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 75349114561     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.03.007     Document Type: Article

References (26)

1. Funder J.W. The nongenomic actions of aldosterone. Endocr Rev 26 (2005) 313-321
2. Rossi G.P., Bernini G., Desideri G., Fabris B., Ferri C., Giacchetti G., et al. PAPY study participants. Renal damage in primary aldosteronism: results of the PAPY study. Hypertension 48 (2006) 232-238
3. Giacchetti G., Sechi L.A., Rilli S., and Carey R.M. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab 16 (2005) 120-126
4. Rossi G.P., Sechi L.A., Giacchetti G., Ronconi V., Strazzullo P., and Funder J.W. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 19 (2008) 88-90
5. Fallo F., Veglio F., Bertello C., Sonino N., Della Mea P., Ermani M., et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91 (2006) 454-459
6. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Prately R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
7. Adamczak M., Wiecek A., Funahashi T., Chudek J., Kokot F., and Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 16 (2003) 72-75
8. Daniele A., Cammarata R., Pasanisi F., Finelli C., Salvatori G., Calcagno G., et al. Molecular analysis of the adiponectin gene in severely obese patients from Southern Italy. Ann Nutr Metab 53 (2008) 155-161
9. Vasseur F., Helbecque N., Dina C., Lobbens S., Delannoy V., Gaget S., et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocytes-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11 (2002) 2607-2614
10. Giacchetti G., Ronconi V., Lucarelli G., Boscaro M., and Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens 24 (2006) 737-745
11. National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation and treatment of high blood cholesterol in adults: executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 (2001) 246-249
12. Milliez P., Girerd X., Plouin P.E., Blacher J., Safar M.E., and Mourad J.J. Evidence of an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45 (2005) 1243-1248
13. Bo S., Gentile L., Ciccone G., Baldi C., Benini L., Dusio F., et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev 21 (2005) 515-524
14. Feder M.E. Evolvability of physiological and biochemical traits: evolutionary mechanisms including and beyond single-nucleotide mutation. J Exp Biol 210 (2007) 1653-1660
15. Yang S.W., and Chuang L.M. Human genetics of adiponectin in the metabolic syndrome. J Mol Med 84 (2006) 112-121
16. Yang W.S., Tsou P.L., Lee W.J., Tseng D.L., Chen C.L., Peng C.C., et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 81 (2003) 428-434
17. Ukkola O., Ravussin E., Jacobson P., Sjostrom L., and Bouchard C. Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism 52 (2003) 881-884
18. Menzaghi C., Ercolino T., Di Paola R., Berg A.H., Warram J.H., Scherer P.E., et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51 (2002) 2306-2312
19. Xita N., Georgiou I., Chatzikyriakidou A., Vounatsou M., Papassotiriou G.P., Papassotiriou I., et al. Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 51 (2005) 416-423
20. Filippi E., Sentinelli F., Trischitta V., Romeo S., Arca M., Leonetti F., et al. Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 12 (2004) 199-205
21. Zacharova J., Chiasson J.L., and Laakso M. The common polymorphisms (single nucleotide polymorphisms SNP + 45 and SNP + 276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM Trial. Diabetes 54 (2005) 893-899
22. Hu F.B., Doria A., Li T., Meigs J.B., Liu S., Memisoglu A., et al. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 53 (2004) 209-213
23. Giacchetti G., Ronconi V., Turchi F., Agostinelli L., Mantero F., Rilli S., et al. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 25 (2007) 177-186
24. Fallo F., Della Mea P., Sonino N., Bertello C., Ermani M., Vettor R., et al. Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens 20 (2007) 855-861
25. Debard C., Laville M., Berbe V., Loizon E., Guillet C., Morio-Liondore B., et al. Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients. Diabetologia 47 (2004) 917-925
26. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451